RNU6-572P

Across TCGA pan-cancer cohorts, RNU6-572P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-572P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-572P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-572P expression acts as an unfavorable survival marker, although some lineages such as ESCA and OV show a favorable association.

UCEC, THCA, and BLCA are the cancer types where RNU6-572P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.107	0.681	<.001	90	view →
THCA	OS	Tertile	II,III,IV	0.150	0.903	<.001	66	view →
BLCA	DFS	Tertile	All	0.210	0.629	.002	45	view →
ESCA	DFS	Tertile	II,III,IV	0.712	0.288	.035	21	view →
LGG	OS	Tertile	All	0.153	0.525	.002	21	view →
OV	OS	Tertile	All	1.000	0.684	.048	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-572P–UCEC (OS)

Open the UCEC breakdown →